145 related articles for article (PubMed ID: 7870909)
1. Lack of cross-sensitization between the locomotor-activating effects of bromocriptine and those of cocaine or heroin.
Hoffman DC; Wise RA
Psychopharmacology (Berl); 1993; 110(4):402-8. PubMed ID: 7870909
[TBL] [Abstract][Full Text] [Related]
2. Locomotor-activating effects of the D2 agonist bromocriptine show environment-specific sensitization following repeated injections.
Hoffman DC; Wise RA
Psychopharmacology (Berl); 1992; 107(2-3):277-84. PubMed ID: 1535445
[TBL] [Abstract][Full Text] [Related]
3. Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization.
De Vries TJ; Schoffelmeer AN; Binnekade R; Raasø H; Vanderschuren LJ
Neuropsychopharmacology; 2002 Jan; 26(1):18-26. PubMed ID: 11751029
[TBL] [Abstract][Full Text] [Related]
4. Prior experience with bromocriptine in the home cage attenuates locomotor sensitization in rats.
Kelsey JE; Carlezon WA
Behav Brain Res; 2002 Aug; 134(1-2):1-8. PubMed ID: 12191786
[TBL] [Abstract][Full Text] [Related]
5. Involvement of D1 and D2 dopamine systems in the behavioral effects of cocaine in rats.
Ushijima I; Carino MA; Horita A
Pharmacol Biochem Behav; 1995 Dec; 52(4):737-41. PubMed ID: 8587913
[TBL] [Abstract][Full Text] [Related]
6. The dopamine D2 receptor agonists, quinpirole and bromocriptine produce conditioned place preferences.
Hoffman DC; Dickson PR; Beninger RJ
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(2-3):315-22. PubMed ID: 2968613
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of 7-OH-DPAT on the development of behavioral sensitization to apomorphine and cocaine.
Mattingly BA; Caudill A; Abel M
Pharmacol Biochem Behav; 2001 Mar; 68(3):417-26. PubMed ID: 11325394
[TBL] [Abstract][Full Text] [Related]
8. Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats.
Neisewander JL; Lucki I; McGonigle P
Pharmacol Biochem Behav; 1996 Apr; 53(4):935-42. PubMed ID: 8801600
[TBL] [Abstract][Full Text] [Related]
9. Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline I2 receptors.
Culver KE; Szechtman H
Psychopharmacology (Berl); 2003 May; 167(2):211-8. PubMed ID: 12652347
[TBL] [Abstract][Full Text] [Related]
10. Effects of daily SKF 38393, quinpirole, and SCH 23390 treatments on locomotor activity and subsequent sensitivity to apomorphine.
Mattingly BA; Rowlett JK; Lovell G
Psychopharmacology (Berl); 1993; 110(3):320-6. PubMed ID: 7831425
[TBL] [Abstract][Full Text] [Related]
11. Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A(2A) receptors.
Fenu S; Cauli O; Morelli M
Behav Brain Res; 2000 Sep; 114(1-2):97-105. PubMed ID: 10996051
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of the locomotor-sensitizing effects of the D2 dopamine agonist bromocriptine by either the D1 antagonist SCH 23390 or the D2 antagonist raclopride.
Wise RA; Carlezon WA
Synapse; 1994 Jul; 17(3):155-9. PubMed ID: 7974197
[TBL] [Abstract][Full Text] [Related]
13. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
Rowlett JK; Platt DM; Yao WD; Spealman RD
J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
[TBL] [Abstract][Full Text] [Related]
14. Ontogeny of biphasic locomotor effects of quinpirole.
Van Hartesveldt C; Meyer ME; Potter TJ
Pharmacol Biochem Behav; 1994 Jul; 48(3):781-6. PubMed ID: 7938135
[TBL] [Abstract][Full Text] [Related]
15. Microinjection of the D2 agonist quinpirole into the A10 dopamine region blocks amphetamine-, but not cocaine-stimulated motor activity.
Steketee JD; Kalivas PW
J Pharmacol Exp Ther; 1992 May; 261(2):811-8. PubMed ID: 1349649
[TBL] [Abstract][Full Text] [Related]
16. Repeated 7-OH-DPAT treatments: behavioral sensitization, dopamine synthesis and subsequent sensitivity to apomorphine and cocaine.
Mattingly BA; Fields SE; Langfels MS; Rowlett JK; Robinet PM; Bardo MT
Psychopharmacology (Berl); 1996 May; 125(1):33-42. PubMed ID: 8724446
[TBL] [Abstract][Full Text] [Related]
17. Dopamine 'D2-like' receptor agonists in combination with cocaine: absence of interactive effects on locomotor activity.
Tirelli E; Reggers J; Terry P
Behav Pharmacol; 1997 Jun; 8(2-3):147-59. PubMed ID: 9833010
[TBL] [Abstract][Full Text] [Related]
18. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
Cauli O; Morelli M
Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482
[TBL] [Abstract][Full Text] [Related]
19. Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole.
Szechtman H; Dai H; Mustafa S; Einat H; Sullivan RM
Pharmacol Biochem Behav; 1994 Aug; 48(4):921-8. PubMed ID: 7972297
[TBL] [Abstract][Full Text] [Related]
20. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
Garrett BE; Holtzman SG
Eur J Pharmacol; 1994 Sep; 262(1-2):65-75. PubMed ID: 7813580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
